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Clinics and pathology 
Disease 
Acute non lymphocytic leukaemia (ANLL) 
Epidemiology 
+4 as the sole anomaly is a rare chromosomal 
abnormality associated with a specific subtype of 
primary ANLL and secondary (treatment related) 
ANLL with myelomonocytic morphology; it has been 
found with the same frequence in the M1-M2 and M4 
French-American-British (FAB) phenotypes. 
Association of +4 with double minute chromosomes 
has been described in ten cases; five with AML-M2, 
two with AML-M4, one with refractory anemia with 
excess of blasts in transformation (RAEB-T), one with 
chronic myelomonocytic leukemia (CMMoL) and one 
with unclassified preleukemia. 
The coincidence of +4 with t(8;21) or its variant 
t(6;21;8), observed in at least two cases of ANLL (M1 
and M2), is therefore recurrent. 
Prognosis 
Apparently +4 has no prognostic significance in 
ANLL; with the exception of the cases bearing c-Kit 
mutations who are associated with a rapid disease 
progression. 
Disease 
Acute lymphocytic leukaemia (ALL) 
Epidemiology 
+4 has been described in two cases of T-cell acute 
lymphoblastic leukemia as the sole chromosomal 
anomaly. 
Combined trisomies of chromosomes 4 and 10 are 
found in children with B-progenitor cell acute 
lymphoblastic leukemia with a favourable prognostic 
association. 
Prognosis 
Patients with chromosomes 4 and 10 trisomies have an 
extremely favourable 4-year event-free survival (EFS) 
after antimetabolite-based chemotherapy. 
Disease 
Thecoma of the ovary 
Epidemiology 
+4 associated with +12 has been described in two cases 
of fibrothecoma and in one case of thecoma; it has been 
suggested that acquisition of trisomy 4 may constitute a 
second cytogenetic step in tumor progression of 
ovarian thecoma/fibrothecoma. 
Prognosis 
No prognostic significance. 
Disease 
+4 has been found as the sole aberration only in one 
case of uterine leiomyoma. 
Genetics 
Note 
Trisomy 4 was proven to lead to duplication of 
Asp816Tyr mutation of c-Kit gene (that maps to 4q12) 
in a case of M2-ANLL with mast cell involvement. 
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